FREDUN PHARMACEUTICALS
Back to Income Statement
|
FREDUN PHARMACEUTICALS Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹348 Cr | ₹275 Cr | ₹224 Cr | ₹134 Cr | ₹11,277,136 Cr |
What is the latest Revenue of FREDUN PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹348 Cr |
| Mar2024 | ₹275 Cr |
| Mar2023 | ₹224 Cr |
| Mar2022 | ₹134 Cr |
| Mar2021 | ₹11,277,136 Cr |
How is Revenue of FREDUN PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹348 Cr | 26.75 | |
| Mar2024 | ₹275 Cr | 22.37 | |
| Mar2023 | ₹224 Cr | 67.64 | |
| Mar2022 | ₹134 Cr | -100.00 | |
| Mar2021 | ₹11,277,136 Cr | - | |
Compare Revenue of peers of FREDUN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FREDUN PHARMACEUTICALS | ₹842.1 Cr | -5.3% | 0.5% | 136.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,531.0 Cr | 1.3% | 8.9% | 6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,989.0 Cr | 2.4% | 6% | 12.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,936.0 Cr | -0.6% | 9.4% | 44.1% | Stock Analytics | |
| CIPLA | ₹109,200.0 Cr | 1.9% | 2% | -8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,057.0 Cr | -0.4% | 9.5% | 10.5% | Stock Analytics | |
FREDUN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FREDUN PHARMACEUTICALS | -5.3% |
0.5% |
136.8% |
| SENSEX | -3.7% |
-2.5% |
6.5% |
You may also like the below Video Courses